Gilead to layoff 20% of sales force

Posted on April 10, 2019 by Medtech[y] Staff

Gilead Sciences has confirmed to STAT that they are laying off approximately 20% of their sales force, which comes to 150 sales representatives in Gilead's cardiopulmonary division.

According to the report, there is concern that Gilead's executive team is struggling to find ways to grow revenue as their older drugs, Ranexa and Letairis, have recently lost patent exclusivity.

A spokesperson confirmed the layoffs to STAT and shared they are an "unfortunate but necessary cost cutting move."

The layoffs are effective July 1.

Join the discussion on our Gilead Company Forum.

Are you a recruiter or company looking to fill a Medical Sales opening, including the medical device or biotech industries? If so, checkout Medtechy Jobs and create a free employer account or a free candidate account. All of our jobs are strategically distributed to our diverse following of experienced and those new to the industry. Multi-pack jobs start at $100.

We are also excited to launch Medtechy Deals, our new store which sources deals on gadgets, everyday carry essentials and online courses for employees in the healthcare industry!

Please follow us on Facebook, Twitter, and LinkedIn for the latest medical technology news, medical device/biotech company intel and career opportunities. You can also sign up for our monthly newsletter.